Supplement 2 || Evaluation and Validation Issues in the Development of Transgenic Mouse Carcinogenicity Bioassays
โ Scribed by Raymond W. Tennant
- Book ID
- 124291074
- Publisher
- Environmental Health Information Service
- Year
- 1998
- Tongue
- English
- Weight
- 751 KB
- Volume
- 106
- Category
- Article
- ISSN
- 0091-6765
- DOI
- 10.2307/3433797
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The dermal Tg.AC transgenic mouse model has been proposed as a potential alternative to the conventional (e.g. oral, dermal, parenteral, inhalation, etc.) 2-year rodent bioassay for detecting chemical carcinogenicity. The present study was designed to address a number of technical aspects of this mo
Three genotoxic mouse carcinogens, 4 c h l o r wphenylenediamine (4-C-o-PDA), 2-nitro-p-phenylenediamine (2-N-pPDA), and 2,4diaminotoluene (2,4-DAT), were tested in the Big BlueTM transgenic mouse mutation assay. Each experiment consisted of a vehicle control group with ten Big BlueTM C57BL/6 mice,
As a contribution to the second round of rodent carcinogenesis prediction organised by the U.S. National Institute of Environmental Health Sciences (NIEHS), speculative predictions for 30 chemicals currently under evaluation in U.S. National Toxicology Program (NTP) rodent bioassays are presented. C